We report a case of a rapidly progressing, relapsing-remitting, steroid-responsive granulocytic encephalitis without any signs of peripheral nervous system or other organ involvement. It apparently had an immune-mediated etiology that could not be attributed to any known disease entity. A 22-year-old man presented with rapidly progressive severe neurological symptoms caused by encephalitis. Examination of the cerebrospinal fluid as well as brain biopsy showed extensive accumulation of neutrophilic granulocytes with no hints of an infectious agent. Magnetic resonance imaging revealed multiple T2/FLAIR demarcated lesions. Subsequent to a steroid pulse therapy, the clinical symptoms and imaging abnormalities improved rapidly. Ten months later, the patient experienced a disease relapse, which again responded well to steroids. Forty months after the relapse, he is currently doing well on azathioprine. This case highlights that an immunosuppressive treatment should be considered in patients with extensive neutrophilic encephalitis when no infectious agent is detected. A new immune-mediated relapsing-remitting CNS disease entity might need to be considered.
INTRODUCTION
The role of neutrophils in the response of the immune system has traditionally been associated with bacterial infections that are usually treated with antibiotic regimens. However, neutrophils can play significant roles in the regulation of the immune response in nonbacterial inflammatory diseases, including those that are immune-mediated (1-4) and viral (5) .
This strongly suggests that the role of neutrophils in regulating the immune system goes beyond the traditionally accepted role as a responsive cellular event to bacterial infections. It is important for clinicians to keep this in mind when considering differential diagnosis in cases of neutrophilic encephalitis. We present a patient with recurrent epileptic seizures and neurological deficits associated with neutrophilic encephalitis, and who benefited from immunosuppression.
CASE REPORT
A 22-year-old man was first admitted to our hospital in August 2013 because of an isolated dyscognitive seizure. The patient had no pre-existing medical conditions, significant travel history, or animal contacts and his family history was negative for neurological diseases. After admission, the patient experienced a series of self-limiting focal fits with residual aphasia, facial palsy, and dysarthria; all increasing in severity over a period of 48 hours. MRI revealed a partially contrast-enhancing, left sided temporal lesion of unknown origin ( Fig. 1A) with a left-sided laminar necrosis in the frontal lobe. The initial workup included a lumbar puncture and screening for antineuronal antibodies. The cerebrospinal fluid examination revealed a total of 69 (mostly granulocytic) cells/mL. Antibiotic treatment with ceftriaxone, ampicillin and acyclovir was discontinued when tests for infectious agents came back negative. The patient was also tested for paraneoplastic and antithyroid antibodies. The results of all examinations were negative. Treatment with methylprednisolone 2 g/day given intravenously (i.v.) on 5 consecutive days led to clinical improvement. The number of cells found in a repeat lumbar puncture had decreased to 8 cells/mL. The patient was subsequently discharged with a residual aphasia to a rehabilitation facility with an antiepileptic treatment of levetiracetam 2 g/day taken orally.
The patient was re-admitted 5 months later with a rightsided, slowly expanding hypoesthesia and progressive aphasia. Examination of the cerebrospinal fluid showed 64 (mostly granulocytic) cells/mL. Neural autoantibody diagnostics as well as fluorescence-activated cell sorting (FACS) analysis were negative. The patient was discharged with an antiepileptic therapy consisting of levetiracetam 3 g/day and of lacosamid 100 mg/day, both taken orally. An MRI scan had shown minimal regression of the lesions. Thus, no steroids were administered.
The patient relapsed again 14 months after the initial presentation, with a series of complex partial epileptic seizures. On clinical examination, the patient showed signs of severe psychomotor impairment and apraxia. CT scanning revealed a new hypodense lesion in the right frontal lobe. The EEG showed a bifrontal theta frequency range with no epileptogenic potentials. The blood panel revealed a minimal increase in the number of total leucocytes (11.42/nL) with an increased proportion of neutrophil granulocytes (82.3%). C-reactive protein was only slightly elevated (8.3 mg/dL). Lumbar puncture showed a spinal fluid with 21 granulocytic cells/mL, positive IgM and IgG synthesis, a disrupted bloodbrain barrier, increased protein concentration and slightly decreased lactate levels. Oligoclonal bands were negative. FACS analysis of the cerebrospinal fluid revealed infiltrations by mostly monocytes (50%) and granulocytes (35%) with no indication of monoclonal B-cell proliferation. Histopathological analysis of cerebrospinal fluid from 2 consecutive lumbar punctures in 2014 had both revealed cell infiltrations dominated by neutrophil granulocytes. Bacterial polymerase chain reaction (PCR) of the cerebrospinal fluid showed no trace of an infectious agent. Cerebrospinal fluid PCR analysis was negative for listeria monocytogenes, borrelia burgdorferi, treponema pallidum, mycobacterium tuberculosis, herpes simplex virus 1 and 2, varicella as well as cytomegaloviruses and also toxoplasma gondii. IgM for FSME, enteroviruses, Epstein-Barr virus were also negative, as were IgG for measles and rubella. Blood PCR analysis was negative for Mycoplasma pneumoniae, Chlamydia pneumoniae, and HIV. Antineuronal antibodies were also negative (ANNA-3 One day after his admission the condition of the patient deteriorated suddenly. He developed a left-sided hemiparesis and a progressive reduction in consciousness as well as singultus. MRI demonstrated a new FLAIR hyperintense lesion in the right frontal lobe with contrast enhancement (Fig. 1B) . There was no evidence of ischemic lesions or microbleedings. Arterial angiography (DSA) showed no caliber irregularities of the intracerebral vessels or other signs of vasculitis. Because of the rapid clinical deterioration, a biopsy of the brain tissue and the meninges was performed promptly. The tissue was described to be of a coarse consistency. The histological analysis showed an extensive inflammatory cell infiltration by predominantly neutrophil cells both in the white and grey matter ( Fig. 2A) . Figure 2B depicts extensive perivascular infiltration by neutrophil granulocyte cells. The cells were mostly found in the perivascular space, while the principle vessel wall structure was well preserved (Fig. 2C) . Also, limited numbers of erythrocytes and substantial deposits of fibrinoid material were found in the perivascular space (Fig. 2D) . Large pockets of neutrophils were also observed in the subarachnoid space. There were no signs of demyelination and no infectious agent was histologically evident. The PCR analysis of the brain biopsy was negative for Tropheryma whipplei and Mycoplasma pneumoniae.
Immunosuppressive treatment with 2 g i.v. of methylprednisolone over 3 consecutive days was begun. Antibiotic treatment was not initiated. The patient's condition improved significantly under the immunosuppressive regimen. A CT scan of the chest and abdomen found no signs for any additional organ manifestations, or signs of a neoplasm. A lumbar puncture performed before discharge revealed a normal cell count. Brain MRI confirmed both a regression of the size of the lesions as well as a reduction of contrast enhancement (Fig. 1C) . The patient was discharged with a recommended maintenance dose of 20 mg/d of methylprednisolone to take orally and an intensified antiepileptic regimen with Levetiracetam. The patient received intensive neurological rehabilitation following the inpatient treatment. After the end of his rehabilitation, the patient was followed in our outpatient clinic. The maintenance dose of corticosteroids was gradually reduced to 2 mg prednisolone per day, and was supplemented by treatment with azathioprine. Azathioprine doses were increased step-wise and continued with 2.5 mg/kg to the present time. In June 2015, the patient was readmitted once more because of a self-limiting episode of singultus, headache and tinnitus. The MRI scan revealed no signs of disease progression and no other complications occurred. The patient was last seen in our outpatient clinic in February 2018, 4.5 years after the initial presentation. He reported that he had not experienced any seizures or neurological deterioration since his discharge in November 2014 and was able to resume full time work as a painter. There were no neurological deficits found on clinical examination. Brain MRI showed that all brain lesions had decreased in size and contrast enhancement was no longer visible (Fig. 1D) . MRI imaging had not revealed microbleedings or ischemic lesions as are typically seen in cases of CNS vasculitis at any point.
DISCUSSION
Here, we report a case of a relapsing-remitting inflammatory brain disease characterized by neutrophilic CSF pleocytosis and neutrophil brain tissue infiltration. MRI scans during the active disease phases revealed T2-positive, partially contrast-enhancing lesions that were responsive to immunosuppressive treatment with steroids. No infectious etiology was detectable. Repeated lumbar punctures, FACS analysis and histopathological analysis of the brain biopsy all indicated infiltrations by mostly neutrophil granulocyte cells. The fact that the introduction of an immunosuppressive regimen led to a quick recovery and improvement of symptoms, the second time without any concurrent antibiotics, suggested that the pathophysiology of the disease was of an immune-mediated nature.
A demyelinating inflammatory autoimmune disease such as multiple sclerosis was ruled out since there were no corresponding findings in the brain biopsy, no typical imaging findings, and oligoclonal bands had been repeatedly negative. A viral, bacterial, or fungal infection was also very unlikely due to the chronic relapsing-remitting nature of the disease. Moreover, there was repetitive and long-lasting clinical improvement with immunosuppressive therapy. 
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Similar findings in the brain biopsy have been reported in patients suffering from Neuro-Sweet disease. The neurological manifestations of that disease ranged from prolonged cognitive decline to severe cases of meningoencephalitis (6) (7) (8) . Biopsies revealed extensive perivascular infiltrates with granulocytes, macrophages and histiocytic cells. The diagnosis was made using brain biopsy and HLA typing. The patients were either HLA B51-or HLA B54-positive and had typical dermatologic findings. Nakanishi et al published 1 case of a neuro-neutrophilic disease in an HLA B54-positive patient that showed no signs of dermatological involvement (9) . In our case, however, the patient was negative for both HLA subtypes typically associated with Neuro-Sweet disease and had no skin involvement, making this differential diagnosis very unlikely.
Neutrophil infiltrates can also be found in cases of systemic vasculitis. The histology of the brain biopsy in our patient showed similarities to those found in patients suffering from leucocytoclastic vasculitis. However, this disease is also associated with a high prevalence of skin lesions. We found 2 cases which reported clinical symptoms in patients with leucocytoclastic vasculitis limited to intracerebral involvement (10, 11) . The histology of the brain biopsy showed mostly transmural and perivascular small vessel inflammatory infiltrates of mostly neutrophil cells, and the clinical symptoms were responsive to treatment with oral prednisolone and improved within several days of treatment onset. The MRI examinations had shown confluent lesions in the subcortical white matter that improved after the immunosuppressive treatment. No ischemic lesions, vessel abnormalities, or microbleedings had been detected in these cases. In both cases, the clinical examinations and the result of MRI scans were inconclusive. In contrast, in our case, a granulocytic meningoencephalitis was the most likely histopathological diagnosis. There were no relevant deposits of immunoglobulin M or C3, and only slightly elevated deposits of immunoglobulin G, which are typically found in the majority of cases with leucocytoclastic vasculitis (12) . Our case is rare in that we were not able to attribute our findings to any defined disease entity, and that the clinical presentation, histopathological analysis and rapid progression of the disease were atypical for an immune-mediated disease limited to intracerebral involvement. Similar cases discussed above had a slower progression of symptoms, mostly of cognitive decline, over a period of several weeks. In our case, the patient presented with seizures and demonstrated a rapid progression of the disease within several days during hospital treatment, with both clinical deterioration in the form of a new hemiparesis and reduction of consciousness, as well as massive progression of lesions in MRI.
CONCLUSIONS
This case highlights the potential contribution of neutrophil granulocytes in the process of immune-mediated diseases. It is important that physicians are aware that immunemediated diseases of the CNS can be dominated by, and may even be caused by, neutrophil granulocyte cells. This is of particular relevance in view of the excellent repeated response to steroids and finally azathioprine seen in our patient. This therapeutic approach might be problematic if neutrophilic brain infiltrates are too quickly attributed to an infectious etiology. Therefore, if the clinical presentation does not fit the typical pattern of known infectious encephalitis, no infectious agent can be detected, and granulocytes are massively present in the brain biopsy, steroids and azathioprine in the case of disease relapse should be considered.
